Matches in Wikidata for { <http://www.wikidata.org/entity/Q63011242> ?p ?o ?g. }
Showing items 1 to 43 of
43
with 100 items per page.
- Q63011242 description "clinical trial" @default.
- Q63011242 description "ensayu clínicu" @default.
- Q63011242 description "klinisch onderzoek" @default.
- Q63011242 description "клінічне випробування" @default.
- Q63011242 description "կլինիկական փորձարկում" @default.
- Q63011242 name "Phase II Study of the CD38 Antibody Daratumumab in Patients With High-Risk MGUS and Low-Risk Smoldering Multiple Myeloma" @default.
- Q63011242 type Item @default.
- Q63011242 label "Phase II Study of the CD38 Antibody Daratumumab in Patients With High-Risk MGUS and Low-Risk Smoldering Multiple Myeloma" @default.
- Q63011242 prefLabel "Phase II Study of the CD38 Antibody Daratumumab in Patients With High-Risk MGUS and Low-Risk Smoldering Multiple Myeloma" @default.
- Q63011242 P1050 Q63011242-8DA0B459-EE5F-4057-B33E-57F3803E3996 @default.
- Q63011242 P1132 Q63011242-756909B1-221B-45E4-A678-9E449C46F5D2 @default.
- Q63011242 P1476 Q63011242-A02C01FF-BC58-4D16-9349-9BDC31561088 @default.
- Q63011242 P17 Q63011242-D3E4241B-C8B1-47BF-B46E-52E1F1D5DDFB @default.
- Q63011242 P2899 Q63011242-75A0D562-A722-4D44-A0CB-FFDCEB44A387 @default.
- Q63011242 P3098 Q63011242-65B28285-0BCD-4BD3-8B5F-A373B87A6C97 @default.
- Q63011242 P31 Q63011242-E1ADA5EA-CF2E-4FFC-9ADC-495D30047ACE @default.
- Q63011242 P4844 Q63011242-4576D173-D7BA-4EBB-9222-BA0EAA4F1015 @default.
- Q63011242 P580 Q63011242-612DCBFE-6E72-40C2-BEBC-E1C3535374D7 @default.
- Q63011242 P582 Q63011242-B9A4808D-28B4-44C1-82B0-2973A3EE6F3A @default.
- Q63011242 P6099 Q63011242-8F92B60F-6E8E-411C-9A70-14F2F93E9140 @default.
- Q63011242 P6153 Q63011242-0771B3C0-F394-419A-9FE0-CCEFB243EBBF @default.
- Q63011242 P6153 Q63011242-6FF1555D-072D-4EF0-8A96-48CEAC928D21 @default.
- Q63011242 P6153 Q63011242-7E936ACC-53C8-41EE-BA69-58768F37E836 @default.
- Q63011242 P6153 Q63011242-8094B23A-1017-48AA-92A3-9B89F4DB47C6 @default.
- Q63011242 P8363 Q63011242-CD363A44-80E8-4393-ABC7-4EDCCBE3F04E @default.
- Q63011242 P859 Q63011242-793719F0-6BBF-4547-97A8-4032F769D727 @default.
- Q63011242 P1050 Q467635 @default.
- Q63011242 P1132 "+40" @default.
- Q63011242 P1476 "A Phase II Study of the CD38 Antibody Daratumumab in Patients With High-Risk MGUS and Low-Risk Smoldering Multiple Myeloma" @default.
- Q63011242 P17 Q30 @default.
- Q63011242 P2899 "+18" @default.
- Q63011242 P3098 "NCT03236428" @default.
- Q63011242 P31 Q30612 @default.
- Q63011242 P4844 Q5222113 @default.
- Q63011242 P580 "2017-11-24T00:00:00Z" @default.
- Q63011242 P582 "2020-08-31T00:00:00Z" @default.
- Q63011242 P6099 Q42824440 @default.
- Q63011242 P6153 Q1159198 @default.
- Q63011242 P6153 Q126412 @default.
- Q63011242 P6153 Q43896855 @default.
- Q63011242 P6153 Q4897536 @default.
- Q63011242 P8363 Q78089383 @default.
- Q63011242 P859 Q1159198 @default.